Skip to main content

Table 1 Relationships between LMR, NLR, PLR and clinicopathologic features of 147 all patients

From: Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy

Characteristics

Total patients

LMR

NLR

PLR

<4

(n = 64)

≥4

(n = 83)

p value

1.6<

(n = 37)

≥1.6

(n = 110)

p value

147<

(n = 79)

≥147

(n = 68)

p value

Age (years)

 

65.8 ± 7.4

65.7 ± 8.2

0.934

65.4 ± 8.0

65.9 ± 7.9

0.72

66.8 ± 8.1

64.6 ± 7.6

0.097

Gender

   

0.052

  

0.163

  

0.562

 Male

132

61

71

 

31

101

 

72

60

 

 Female

15

3

12

 

6

9

 

7

8

 

WBC

 

6082.2 ± 2153.2

5844.3 ± 1788.2

0.466

5284.1 ± 1667.3

6171.2 ± 1996.5

0.016

6190.9 ± 1723.0

5665.6 ± 2167.2

0.104

 Neutrophil

 

3944.7 ± 1804.6

3412.8 ± 1470.4

0.051

2491.0 ± 948.3

4032.3 ± 1643.7

<0.0001

3509.3 ± 1300.5

3801.3 ± 1960.9

0.283

 Lymphocyte

 

1322.0 ± 546.4

1942.5 ± 584.5

<0.0001

2187.6 ± 658.6

1499.0 ± 541.8

<0.0001

2029.2 ± 586.3

1257.7 ± 426.2

<0.0001

 Monocyte

 

546.8 ± 211.3

328.7 ± 111.1

<0.0001

379.0 ± 161.3

438.7 ± 203.3

0.1074

418.2 ± 171.3

430.0 ± 220.2

0.714

Platelet

 

236.6 ± 79.2

226.9 ± 66.2

0.42

231.0 ± 76.9

231.2 ± 70.7

0.987

203.5 ± 49.2

263.2 ± 80.9

<0.0001

Location of tumor

   

0.09

  

0.313

  

0.042

 Ce

6

5

1

 

1

5

 

0

6

 

 Ut

8

4

4

 

0

8

 

5

3

 

 Mt

65

29

36

 

20

45

 

32

33

 

 Lt

52

23

29

 

11

41

 

31

21

 

 Ae

16

3

13

 

5

11

 

11

5

 

Tumor size (mm)

 

4.9 ± 1.9

3.9 ± 2.7

0.014

3.8 ± 2.8

4.5 ± 2.3

0.134

4.0 ± 2.5

4.8 ± 2.3

0.056

Depth of tumor

   

0.0007

  

0.002

  

0.06

 T1a-1b

66

20

46

 

18

48

 

40

26

 

 2

12

2

10

 

8

4

 

9

3

 

 3

56

33

23

 

8

48

 

26

30

 

 4a-4b

13

9

4

 

3

10

 

4

9

 

Lymph node metastasis

   

0.2732

  

0.1532

  

0.0639

 N0

79

30

49

 

22

57

 

43

36

 

 N1

42

19

23

 

12

30

 

25

17

 

 N2

12

8

4

 

3

9

 

8

4

 

 N3

14

7

7

 

0

14

 

3

11

 

Pathological stage

   

0.0002

  

0.1338

  

0.3497

 1a-1b

59

14

45

 

20

39

 

36

23

 

 2a-2b

33

21

12

 

6

27

 

16

17

 

 3a-3c

55

29

26

 

11

44

 

27

28

 

Operation time (min)

 

644.8 ± 162.2

663.5 ± 159.2

0.4843

655.9 ± 177.2

655.2 ± 155.0

0.9798

676.5 ± 149.0

630.8 ± 170.2

0.0845

Intraoperative blood loss (ml)

 

751.8 ± 622.8

581.6 ± 633.4

0.1059

568.8 ± 511.1

684.9 ± 667.8

0.3359

598.5 ± 633.1

722.2 ± 629.7

0.2384

SCC antigen

 

1.19 ± 1.06

1.12 ± 1.12

0.7208

1.04 ± 1.12

1.19 ± 1.08

0.7643

1.05 ± 0.91

1.27 ± 1.26

0.8858

  1. LMR lymphocyte to monocyte ratio, NLR neutrophil to lymphocyte ratio, PLR platelet lymphocyte ratio
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us